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Abstract
Dosage compensation equates between the sexes the gene dose of sex chromosomes that carry substantially different
gene content. In Drosophila, the single male X chromosome is hypertranscribed by approximately two-fold to effect this
correction. The key genes are male lethal and appear not to be required in females, or affect their viability. Here, we show
these male lethals do in fact have a role in females, and they participate in the very process which will eventually shut down
their function—female determination. We find the male dosage compensation complex is required for upregulating
transcription of the sex determination master switch, Sex-lethal, an X-linked gene which is specifically activated in females in
response to their two X chromosomes. The levels of some X-linked genes are also affected, and some of these genes are
used in the process of counting the number of X chromosomes early in development. Our data suggest that before the
female state is set, the ground state is male and female X chromosome expression is elevated. Females thus utilize the male
dosage compensation process to amplify the signal which determines their fate.
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Introduction
When the sex chromosomes carry substantially different gene
numbers, dosage compensation is necessary to equalize gene
expression between the two sexes. In the three best studied model
systems Drosophila, C. elegans and mammals where males are XY
and females XX, this involves targeting X-specific components
which modify the chromatin and transcription of X-linked genes.
In each of these cases the end result is different; Drosophila
upregulates transcription of the male X by about two-fold, C.
elegans downregulates transcription of both X chromosomes in the
hermaphrodite by approximately half, and mammals generally
shut down transcription of one of the two female X chromosomes
(reviewed in [1]).
As it is the Drosophila male which requires dosage compensation,
mutation of genes strictly dedicated to this process results in male
lethality. The first male specific lethal identified, maleless (mle; [2]),
is indeed involved in dosage compensation as are the next
identified male lethals, msl-1 and msl-2 [3]. msl-3 identified by
Uchida et al. [4] and males absent on the first (mof; [5]) complete the
proteins collectively known as the male specific lethals (msls; reviewed
in [1,6,7]). In addition to these proteins, two RNAs on the X
chromosome (the roX RNAs), which are not present in females, are
also essential for dosage compensation [8]. Although roX1 and
roX2 show no sequence similarity and do not have an open reading
frame that could encode a significantly sized protein, they function
redundantly; either roX is adequate for function, while loss of both
RNAs is required for a failure in dosage compensation and male
lethality [9]. The MSL proteins and roX RNAs function as a
complex, coating the male X chromosome; the X chromosome is
hypertranscribed and MOF acetylates histone H4 on lysine 16.
Finally, a protein that appears to be part of the dosage
compensation complex (DCC) but is required by both sexes is
the JIL histone H3 kinase. JIL is also enriched on the male X
chromosome but its loss leads to lethality in both sexes [10].
In 1980, Skripsky and Lucchessi [11] reported that females
heterozygous for a Sex-lethal (Sxl) null allele, Sxl
f1, and homozygous
for mle showed morphological characteristics indicative of sex
transformations. Sxl is the Drosophila sex determination master
switch, which is on in females but off in males. The Sxl
f1/+; mle/mle
sex transformation result was confirmed and extended by
Uenoyama et al. [12] who observed similar effects with two
different mle alleles as well as msl-2 and msl-3. This argued that this
phenomenon was not unique to mle, but likely a general property
of the msls.
These results, a requirement of male specific genes in females,
present a paradox. First, homozygous msl
2 females show no sex
transformations and are fully viable [3]. Second, besides
controlling differentiation, a key function of Sxl is to turn off the
male dosage compensation system to prevent hypertranscription of
the two female X chromosomes, which would otherwise lead to
female lethality. As a splicing and translation regulator, Sxl alters
the splicing and inhibits translation of msl-2 mRNA so preventing
assembly of the DCC [13–17]. The absence of MSL-2 also
destabilizes MSL-1 and MSL-3 assuring inactivation of the dosage
compensation machinery.
PLoS Genetics | www.plosgenetics.org 1 July 2010 | Volume 6 | Issue 7 | e1001041The initial activation of Sxl is transcriptional, at the Sxl
‘establishment’ promoter, SxlPe [18]. In cycle 12 of embryogenesis,
SxlPe responds to activating X linked genes (known members:
sisterless-a (sis-a), sisterless-b (sis-b), runt (run) and unpaired (upd)), in
conjunction with positive maternal factors such as Daughterless,
balancing their dose against the negative effect of genes on the
autosomes (deadpan (dpn), the only identified member) and maternal
factors such as Groucho (Gro) and Extramacrochetae (hereafter
collectively referred to as the X:A ratio; reviewed in [19]). Protein
from SxlPe transcripts alters the splicing of transcripts from the
‘maintenance’ promoter, SxlPm, first transcribed in cycle 14 in both
sexes. In the absence of Sxl protein, default splicing includes a
translation terminating exon into the transcripts from SxlPm.A s
male embryos do not activate SxlPe, Sxl protein is absent and a
splicing change on SxlPm transcripts is only effected in females.
Females thus set in motion a splicing autoregulatory feedback loop
which serves to maintain Sxl expression, and sexual identity,
through the rest of the life cycle [20].
Returning to the paradox of a female requirement of male
specific genes, one explanation is that XX embryos with only one
copy of Sxl fail to reliably activate the gene. These XX cells would
be male and are presumably eliminated, due to the gene
imbalance from inappropriate dosage compensation. However,
when one or more of the msls is mutant, these masculinized XX
cells might survive since assembly of the male DCC is prevented.
The resulting clones grow but are sexually transformed, so
accounting for the observed sex transformations.
Results
While plausible, the above explanation does not account for the
recessive nature of Sxl null alleles, which have very high viability
(Figure 1A). This high viability requires these females survive the
removal of those pockets of male tissue with inappropriate dosage
compensation, as Sxl hemizygous females show no male differen-
tiation. Figure 1A also shows that the viability of females with only
one Sxl
+ allele is badly compromised if maternal MSL-3 is
removed. Maternal MSL-1 was next most effective followed by
MSL-2, while the effect of MLE was negligible relative to wild
type. These data demonstrate a synergism of these msls with Sxl for
female viability, as one wild type copy of both Sxl and the msl,i s
present in these animals. Contrary to the expectation that female
survival might be improved if partially masculinized tissue did not
perform male dosage compensation effectively, it would appear
that females have a need for the msls, when the dose of Sxl is
halved. Consistent with our findings, some of the Sxl
f1/+; msl/msl
combinations in Uenoyama et al. [12] also showed reduced female
viability.
msls interact with numerator genes for female viability
The above viability results prompted us to analyze whether key
activators of Sxl - the numerator genes sis-a and sis-b, would show a
similar interaction with the msls. Figure 1B shows that the effect of
a sis-a, sis-b double mutant chromosome is more extreme than a
Sxl null, when crossed to mothers mutant for each of the msls. The
Author Summary
When substantially different, sex chromosomes present
the challenge of not only gene dose inequity between the
sexes, in the heterogametic sex where one chromosome
(frequently the Y) carries few genes, but also an inequity
relative to the autosomes which are diploid. Dosage
compensation refers to the process which equates gene
dose between the sexes. Recent results, however, indicate
that the mammalian X chromosome avoids monosomy
and has a level of expression that is two-fold relative to the
autosomes. Hyperactive X chromosome expression in
Caenorhabditis elegans has also been suggested, and
dosage compensation in the hermaphrodite appears to
lower expression of the X chromosomes to match
autosome levels. We find that, before the female state is
set in Drosophila, the X chromosomes may also express
their genes at the two-fold male level and that this level of
expression is used to female advantage to consolidate
their sex determination. Together, the results suggest that
elevated X chromosome expression may be the norm, and
that the various dosage compensation processes different
organisms utilize reflect a mechanism to counteract an
initial hyperactive X chromosome state.
Figure 1. Removal of maternal msls reduces female viability when female determining gene dose is compromised. Genotype of
mothers shown on x-axis; percent female viability relative to their brothers is shown with percentage standard error. (A) Ore R or homozygous mle
1,
msl-1
L60, msl-2
1 or msl-3
1 females mated to y, w, cm, Sxl
fP7B0/Y (test classes total n=439, 1088, 522, 489, 1065, respectively). Females homozygous for
the Sxl
fP7B0 deficiency are lethal but males with the deficiency are viable. (B) Ore R or homozygous mle
1, msl-1
L60, msl-2
1 or msl-3
1 females mated to w,
sis-b
sc3-1, sis-a
1,m /Y (test classes total n=270, 934, 593, 849, 555, respectively).
doi:10.1371/journal.pgen.1001041.g001
Male Lethals for Females
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in a dose sensitive process to activate Sxl and so determine female
sex. What is surprising is that the msls interact with the numerators
to promote female viability.
To test whether the loss of a single numerator gene could also
affectfemales,weperformed crosseswithreduced doseofeithersis-a
or sis-b. Since msl-3 showed the strongest overall interaction, this msl
was examined. Figure 2A shows that sis-a as well as sis-b alone
affected females, with sis-b having the stronger effect. The sis gene
interactions suggest that very early steps in the female sex
determination process are compromised. Testing two Sxl alleles,
an early (Sxl
f9) versus a late (Sxl
M1,f12) defective allele, indicated that
theearly defectiveallelehad aneffect,almostasstrong assis-aalone,
while the late defective allele did not. These data are consistent with
the view that early, dose sensitive eventsinfemale sexdetermination
are influenced by the msls. The late Sxl transcripts may not turnover
or be as dose sensitive as the early transcripts, so a 50% reduction
may not be sufficient to sensitize the females.
sis-a andsis-b arezygoticin theirrole infemale sexdetermination.
To determine whether the effect observed with the msls was
maternalorzygotic,reciprocalcrossestoFigure1Bwereperformed.
Under these conditions, halving the dose of each of the four msls,
including msl-2, reduced female viability (Figure 2B). The zygotic
effect was generally weaker than the maternal.
A maternal effect of msl-2 is surprising given that the protein is not
detected in females[13,15,17]. Wenote that a maternal effect of msl-2
was also described by Uenoyama et al. [12]. msl-2 RNA is deposited
into the egg (Flybase microarray data; http://www.flybase.org/), so
the strength of the zygotic effect is presumably influenced by the
amount of maternal protein/RNA of each of the msls.
As the msls, particularly MSL-3 and MOF, have been shown to
bind to both autosomal and X-linked genes where they might
perform an unknown role, we wondered whether the entire male
DCC, including MOF and the roX RNAs, influenced female
viability. With the numerator gene dose compromised, halving mof
dose had an effect, as did roX1 which was much stronger in effect
than roX2 (Figure 2B). Since the roX RNAs function redundantly,
the impact of roX1 and the weaker interaction of roX2 can be
explained by the fact that first expression during embryogenesis is
later for roX2than for roX1 [9]. Combined, these results indicate
that the msls affect an early event and that the entire male DCC is
required for promoting female viability.
Transcription of Sxl is affected by the msls
The foregoing suggests an event early in Sxl expression is altered
by the DCC. To directly assess the effect of the DCC on Sxl
transcription, in situs were performed with Sxl probes specific for
either the early or late transcripts. Embryos from homozygous
Figure 2. msls act early in the female sex determination process, and all key components of the dosage compensation complex,
affect female viability. (A) msl-3
1 homozygous mothers mated to males mutant for single numerator gene (sis-a
1 or sis-b
sc3-1)o rSxl early phase (f9)
or late phase defective (M1, f12) allele (test class total n=1135, 1047, 879, 404, 1129, 696, 915, 924, respectively). sis-b
sc3-1 cross was done at 29uC, the
non-permissive temperature for this temperature-sensitive allele. Percent viability of females relative to their brothers is shown with percentage
standard error. Relevant genotype of fathers shown on x-axis. (B) w, sis-b
sc3-1, sis-a
1,m /FM7 females were mated to either Ore R, mle
1/CyO, msl-1
L60/
CyO, msl-2
1/CyO, msl-3
1/TM3, mof
2/Y; 18H1[mof
+]/+, roX1
ex6/Y or roX2
2/Y males (test class total n=420, 241, 208, 285, 363, 447, 408, 418,
respectively). Percent viability of sis-a, b/+ females with the msl mutation relative to their FM7/+ sisters also carrying the msl mutation is shown, with
percentage standard error. For mof it is for females that did not receive the 18H1[mof
+] transgene. Relevant msl genotype of fathers shown on x axis.
doi:10.1371/journal.pgen.1001041.g002
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1, msl-1
L-60, msl-2
1, msl-3
1 or roX1
ex6, roX2
2 double
mutant mothers, mated to heterozygous msl males were analyzed.
For the roX1, roX2 double mutant embryos, the roX1
2, roX2
2
males have a duplication of roX2
+ on their Y chromosome so only
the females are roX1
2, roX2
2.
In wild type embryos, SxlPe is not activated until cycle 12, its
expression becomes stronger in cycles 13 and 14 before it rapidly
ceases expression early in cycle 14. For all the msls about half the
embryos showed weaker than normal expression of SxlPe, as judged
by the size and intensity of the in situ dots on their X
chromosomes (Figure 3). The fraction was higher in the roX1
2,
roX2
2 cross where all the females are expected to be mutant.
These data indicate that the entire DCC complex is used to
upregulate transcription from SxlPe.
A constitutive Sxl allele rescues females from msl-
promoted lethality
If, as the data suggest, the primary reason for female lethality is
the failure to activate Sxl, a constitutive allele (such as Sxl
M1) which
bypasses the X:A ratio should rescue them. Since msl-3 showed the
strongest interaction in the genetic tests, we determined whether the
presence of Sxl
M1 could rescue the lethality of sis-a, b or Sxl dose
reduction in embryos from mothers homozygous for msl-3
1. The
rescue (Figure 4) of 72.8% and 98.7% of the females by Sxl
M1 for sis-
a, b or Sxl dose reduction, respectively, demonstrates that female
lethality is primarily caused by the inadequate expression of Sxl.
Both Sxl promoters are affected by the DCC
We next examined whether transcripts from the maintenance
promoter, SxlPm, were affected. As shown in Figure 5, this
promoter was also affected by loss of DCC components. For msl-1,
msl-2 and msl-3 about 50% of the embryos, presumably the
homozygotes, showed weaker expression. For mle and the roX1
2,
roX2
2 double mutants almost all the females (2-dots/cell embryos)
showed weaker than normal expression. As noted for SxlPe, most of
the females are mutant for roX1
2, roX2
2 (excepting the few non-
disjunction embryos that also receive the Y with a duplicated roX2
+
Figure 3. Transcription from the X chromosome dose sensitive
promoter of Sxl, SxlPe, is reduced in embryos homozygous for
the msls. In situs on embryos with an early transcript specific probe
reveals two dots/nucleus at the sites of transcription on the X
chromosomes during cycles 13 and 14 in development. The roX double
mutants had a reduction in expression in most embryos as all the
females are mutant, the msls showed reduced expression in about 50%
of the embryos (crosses described in text). The ‘sibs’ panels show the
signal from normal looking cycle 14 embryos in the same collection,
presumably the heterozygous siblings. NA – not applicable. All embryos
photographed at 406mag.
doi:10.1371/journal.pgen.1001041.g003
Figure 4. A constitutive Sxl allele rescues the female lethality
from loss of msl-3. y, cm, Sxl
M1/FM7; msl-3
1 females mated to w,
sis-b
sc3-1, sis-a
1,m /Y or y, w, cm, Sxl
fP7B0/Y males (test class total
n=555, 851, 1065, 681 respectively). Percent viability of females
relative to their brothers is shown with percentage standard error.
Genotype of fathers shown on x-axis. As the reference males were the
balancer FM7/Y, correction for their reduced viability (48.7%) was
determined relative to Sxl
M1/+ females from a mating of y, cm, Sxl
M1/
FM7; msl-3
1 to Ore R males.
doi:10.1371/journal.pgen.1001041.g004
Figure 5. Transcription from the Sxl maintenance promoter,
SxlPm, is also reduced in embryos homozygous for the msls. In
situs of embryos using a Sxl late transcript specific probe during early
and mid cycle 14. As cellularization proceeds during cycle 14, the
membranes between the nuclei drop into the embryo, the cell volume
changes allowing embryo staging. Only females are shown. Male
embryos also transcribe SxlPm – single X chromosome dots – not shown.
All embryos photographed at 406mag.
doi:10.1371/journal.pgen.1001041.g005
Male Lethals for Females
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1.
The mle
1 data suggest the maternal contribution of MLE is
important for SxlPm expression, an effect that appears distinct from
the loss of the DCC since for SxlPe only half the embryos were
affected. This may be an outcome of SxlPm relying more heavily on
maternal MLE compared to the other msls. Alternatively, because
MLE also affects the stability of roX1 RNA, which has a larger role
in sex determination than roX2 (Figure 2B), the effect of mutating
MLE may be amplified as it not only eliminates the maternal MLE
but also reduces the levels of roX1 RNA, acting as a double
mutation. Despite this unexplained effect on SxlPm by maternal
MLE, the data together indicate that both Sxl promoters are
susceptible to the DCC and suggest that Sxl, which resides on the
X, is a dosage compensated gene. Consistent with the idea that
transcription elongation and not initiation is altered by the DCC
[21], transcription from both Sxl promoters, which are regulated
by different factors, is affected.
Although the in situs of Ore R embryos did not show the
distinctly different classes we observed with the msl embryos, to
control for the possibility that the quality of the in situs was
responsible for generating a poor signal in half the embryos from
msl mutant mothers, in situs for SxlPm transcripts were simulta-
neously performed with a distinguishable second probe - the
segmentation gene hairy which has a striped pattern of expression.
As seen in Figure 6, embryos from msl mutant mothers that are at
the same developmental stage as Ore R embryos have comparable
hairy stripes but poor SxlPm signal, indicating that the poor signal is
not an artifact of the in situs but an effect of the msls on Sxl
transcription.
Quantitation of Sxl expression in embryos from msl
mothers
The in situs are qualitative and the nuclear dots detect
transcription directly off the chromosomes, indicating only high
levels of transcription. For a better measure, we performed
quantitative RT-PCR analysis on 2–3 h and 2.5–3.5 h embryos
for SxlPe and SxlPm expression, respectively. Embryos were from
homozygous mutant mothers for msl-2
1, msl-3
1 or roX1
ex6, roX2
2
double mutants, mated to heterozygous msl males. As for the in
situs, in the roX1
2, roX2
2 embryos only the females are doubly
mutant as males have a duplication of roX2
+ on their Y. RNA
levels were normalized to tubulin levels and compared to Ore R
embryos which were set to 1.
Figure 7 shows that SxlPe is expressed at lower levels than Ore R
embryos in all three msl genotypes. The median for msl-2
1 embryos
was slightly above, for msl-3
1 and roX1
2, roX2
2 embryos the
median slightly below half of Ore R. The medians for SxlPm were
also close to half, except for the roX1
2, roX2
2 genotype which was
closer to 0.7. SxlPm is transcribed in both sexes and all the males
have a functional roX2 gene in the roX1
2, roX2
2 embryos. In these
embryos, SxlPm gave a value of 0.7, suggesting males are
transcribing SxlPm at close to normal levels while the females
express SxlPm at close to half. This would suggest that functional
roX2 RNA is present mid-way through cycle 14, a little earlier than
in situs can detect [9].
A value close to 0.5 for both promoters (excepting SxlPm for
roX1
2, roX2
2) was a little surprising given the in situ results which
show about half the embryos have close to normal levels of
transcription. It suggests that the DCC may be upregulating the
expression of Sxl by a little more than two-fold, not unlike the roX
genes [22]. Alternatively, and not mutually exclusive, it may also
indicate that at 2–3 h of development most of the DCC is
assembled primarily from maternal reserves and the presence of
one wild type chromosome in half the embryos (from the
heterozygous fathers) makes a small contribution. With respect
to SxlPe, the qRT-PCRs score embryos whose average age is
slightly younger than the in situs, at cycles 13 and 14 (2.75–
3.25 h). Close examination of those in situs shows few embryos in
early cycle 13 with uniform, wild type levels of SxlPe expression.
However, when the membranes begin to drop between the nuclei
later in cycle 13, the class with more uniform expression
resembling wild type, is more readily observed (data not shown).
By late cycle 13 and cycle 14, the zygotic contribution of the wild
type chromosome from the heterozygous fathers must begin, and
the two different classes are more readily apparent in cycle 14
embryos (Figure 3). For SxlPm, the data are more consistent with
the DCC having slightly greater than a two-fold effect.
Effects of the DCC were also scored for some of the sex
determination genes in the 2–3 h collections from homozygous msl-
2
1 or msl-3
1 mothers. msl-3
1 embryos show sis-a, like Sxl, with a
medianexpression close to 0.5, while run and dpn gave mediansclose
to 1 as expected for non-dosage compensated genes (sis-b could not
be reliably scored as it has an anti-sense transcript, CG32816). upd
appeared reduced to ,0.7 but this was not statistically significant
and the data showed greater variability than for the other genes.
This may be because upd begins expression later (cyc 13; [23]), and
half the embryos are beginning to perform normal dosage
compensation. Also, there are 2 DCC high-affinity sites (see
Discussion below) relatively close to upd. These are predicted to
make upd less sensitive to the loss of MSL-3, since MSL-3 is required
for spreading of the DCC from its initial entry sites.
For msl-2
1 embryos, the upd median did drop to ,0.5, consistent
with the loss of MSL-2 having a greater effect than MSL-3 for
genes with close DCC entry sites. run did not show a significant
change from wild type. However, unlike for the msl-3
1 embryos,
sis-a was slightly elevated relative to wild type, while dpn mRNA, at
a low level of significance, showed a small decrease. As the msl-3
1
embryos show that sis-a is dependent on the DCC, these latter data
suggest that besides dosage compensation, MSL-2 may have an
additional role, one that perhaps affects mRNA stability. MSL-2
affects the steady state levels of the roX RNAs [24]; such an activity
could explain the greater variability in the values we measured for
Figure 6. Reduced in situ signal in Sxl is not accompanied by
reduced signal in another unrelated gene. In situs for SxlPm
transcripts performed simultaneously with the segmentation gene
hairy. Embryos from msl mothers show the normal hairy striping pattern
of expression for the same developmental stage as Ore R embryos (left
set of panels), but poor SxlPm signal (right set of panels—enlarged view
to show cells). All embryos photographed at 406mag.
doi:10.1371/journal.pgen.1001041.g006
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1 embryos. To test this, in situs of sis-a mRNA were
performed to determine if over time, the mRNA levels would show
a change consistent with accumulation. Indeed, we found this to
be the case (Figure S1), suggesting that in the case of sis-a MSL-2
may serve to destabilize its RNA. During the early cycles, embryos
from msl-2
1 mothers had signal which was generally weaker than
wild type, but by cycle 12 when the message has its highest
accumulation in wild type [25], the accumulated levels in the msl-
2
1 embryos were even higher. While alternative explanations, e.g.
repression of the sis-a promoter by MSL-2 are also plausible, this
effect would have to occur at some but not all stages of sis-a
transcription and be independent of the DCC, as loss of MSL-3
shows the predicted 2-fold drop in sis-a mRNA levels.
Despite the suggestion of an additional role beyond dosage
compensation for MSL-2, the qRT-PCR data show that the 2 Sxl
promoters are expressed at approximately half their normal levels
by the loss of the DCC. Expression of other X-linked genes also
appears to be similarly affected, very clearly evident in the msl-3
1
embryos. This indicates the DCC functions relatively early, and
may also affect the handful of genes known to be expressed during
these early stages of embryonic development [26,27].
Transient expression of the DCC in females
The data argue for a role of the male DCC in females, a
function not ascribed to it, and the complex has not been detected
in female embryos [28–30]. Our data suggest that prior to the full
activation of Sxl there is a brief window of male dosage
compensation in females, after which Sxl protein is predicted to
shut down MSL-2 expression, and destabilize the entire DCC. Not
all anti-MSL antibodies have been reported to detect the complex
at this early stage, even in males (see [30]). Given this limitation,
we used an anti-MSL-1 antibody from the Lucchesi lab which has
high sensitivity and enhanced the signal with an M3TAP construct
[31]. These embryos were co-stained with anti-Sxl antibodies and
closely examined around the cellular blastoderm stage. Figure 8
shows that there is indeed a very brief stage, in mid cycle 14, when
it is possible to simultaneously detect both Sxl and the DCC in
females. The ant-MSL-1 signal in the female nuclei is not as bright
and generally covers an area of DNA larger than in males,
presumably the two X chromosomes.
Discussion
The effect of the DCC on Sxl transcription early in
embryogenesis explains the contradiction of why genes that are
Figure 7. Change in mRNA expression for dosage compensated and control genes compared to Ore R. All replicates are plotted and
display the 25 and 75 percentiles (boxed), median (line in boxes), max and min (whiskers) of the data set. Significance is measured using an unpaired
t-test with a Welch’s variance correction, levels indicated above whiskers as *** for p,.001, ** for .001,p,.01, * for .01,p,.05, and ‘ns’ for p..05. (A)
SxlPe and SxlPm transcripts show a highly significant drop in expression when DCC function is compromised by mutation in msl-2, msl-3 or the roX
genes. Embryo genotype on the x-axis. As noted in the text, the lower significance in the change in SxlPm levels for the roX- genotype is most likely
the influence of males which have a wild type roX2 gene. (B) dpn and run, show almost no significant change in expression, with the slight exception
of dpn in the msl-2
1 mutants. sis-a and upd show significant change in a DCC-compromised backgrounds, with specific differences between mutant
genotypes. sis-a shows the expected drop in expression for msl-3
1embryos but shows a slight increase in expression for msl-2
1embryos. This appears
to arise from an additional role of MSL-2, affecting mRNA levels (see Figure S1). upd is affected by the loss of MSL-2 but is essentially unaffected by
the loss of MSL-3, as would be expected for a gene with close DCC entry sites.
doi:10.1371/journal.pgen.1001041.g007
Figure 8. Sxl and the DCC are transiently co-expressed in
female embryos. During mid cycle 14, Sxl (green) and the DCC (red -
mostly from anti-MSL-1 antibody) can be simultaneously detected in
females. MSL-1 overlaid on DNA (blue) signal (Merge). Top set of images
from males, as determined by the lack of specific Sxl signal, lower set is
of females. The ant-MSL-1 signal in the female nuclei is less intense and
generally covers a larger area than in males, as might be expected for
their double dose of X chromosomes. As previously noted [46], the
signal in males is more frequently at the nuclear periphery.
doi:10.1371/journal.pgen.1001041.g008
Male Lethals for Females
PLoS Genetics | www.plosgenetics.org 6 July 2010 | Volume 6 | Issue 7 | e1001041normally off in females are required to promote their viability. In
the absence of the msls and a functional male DCC, transcription
of some of the genes on the X chromosome as well as Sxl is not
elevated by two-fold. This effectively weakens the X:A ratio and
lowers the levels of the Sxl early as well as late transcripts, which
when low enough leads to female lethality. With respect to SxlPe,
insufficient levels of early protein are produced and splicing of
SxlPm transcripts into the female mode is compromised. With
respect to SxlPm, a reduction may compromise establishment of the
female state as the autoregulatory splicing feedback loop would
have to rely on reduced mRNA and protein levels.
In the absence of mutations in feminizing genes, lowering of Sxl
expression by the msls is not detrimental, presumably as the very
process which would lead to female lethality - male dosage
compensation - is no longer functional, while the Sxl positive
autoregulatory feedback loop slowly establishes itself into the
female state. Without the DCC, however, reduced dose of
feminizing genes, particularly the dose sensing X-linked genes or
numerators, lowers SxlPe transcript levels further, and has
deleterious consequences for females. Sxl dose also has an effect,
but unlike the numerators Sxl is not strictly dose sensitive, and not
unexpectedly, when its copy number is halved, has a less profound
effect on female viability. It should be noted that extremely low
levels of Sxl in females, even in the absence of the male DCC is
lethal [32]. Sxl protein directly performs a female dosage
compensation role, reducing the levels of X-linked genes such as
run [33]; the latter is not upregulated by the male DCC [34;
Figure 7].
Early X chromosome expression is elevated in females
Our data indicate that some of the earliest expressed genes on
the X, the numerators as well as Sxl, are dosage compensated.
Dosage compensation is a chromosome wide phenomenon, and, at
the least, the effect of the msls can be detected as early as cycle 13.
Previous work timed the DCC in males at cellular blastoderm
(Stage 5, [30]) and early gastrulation (Stage 6, [29]). Our data
(qRT-PCRs and in situs) suggest dosage compensation sets in
earlier, by 2–3 h in development and appears to initially rely on
maternal stores and the zygotic expression of the roX RNAs (roX1
primarily). As discussed by McDowell et al. [30] antibody
sensitivity sets the limit for the prior studies. The present studies
relied on different assays, which may account for the difference.
Indeed, we were also unable to detect convincing signal in males,
which is normally stronger, much before blastoderm by antibody
staining (Figure 8). It is also possible that early in development the
DCC is harder to detect directly as there are fewer genes being
transcribed, so less of the complex may have assembled onto the X
chromosome before cycle 14, when the mid-blastula transition
occurs and there is a large transcriptional burst. The zygotic
expression of roX1 RNA has been placed at around 2 h of
embryogenesis [9], consistent with the effects we observe.
Targeting of the DCC to the X chromosome, rather than the
autosomes, is thought to rely on transcription marks, sequence
elements (,150 MREs – MSL recognition elements and ,130
HAS – high affinity sites), and other unknown elements [35,36].
The identified sequence element set is still incomplete since the
two data sets show an overlap of 69%; it is predicted that the X
chromosome may have as many as 240–300 elements (reviewed in
[7]). Examination of the published MRE and HAS shows the
closest element to Sxl ,139 Kbp 59 of the gene. This distance is on
the large side, although it should be noted that all elements which
target the DCC to genes on the X remain to be identified; as an
example, the white gene has its closest known MRE/HAS 93 Kbp
away but its mini form in transgenes, which does not include this
site, is clearly dosage compensated. Finally, ChIP data (mod-
ENCODE, Flybase) show Sxl with strong H4K16 acetylation
marks, a modification dependent on the DCC. ChIP data for JIL-
1 kinase also suggest the DCC is at Sxl.
None of the other sex determination genes, other than upd (two
39 elements at ,5.6 and 6.8 Kbp away) had an element within
10 Kbp (sis-a ,26 Kbp, sis-b ,38 Kbp), consistent with the
observation that the msls involved in spreading the DCC from its
entry sites on the X (MSL-3, MOF and the roX RNAs), are
required for their elevated expression. upd, the exception, showed
greater sensitivity to the loss of MSL-2 than MSL-3, as might be
expected for dosage compensation which is less dependent on
spreading. An interesting correlation is that run which is not
compensated, had its closest elements ,343 (59) and ,273 Kbp
(39) away, further than the rest of the other known key sex
determination genes.
Default mode is male
By using the DCC before the female state is established, Sxl
capitalizes on the default male state. Transcription from SxlPe is
amplified, an effect unique to females as males do not transcribe
from SxlPe. Determination of female identity is thus consolidated.
As expression of Sxl protein levels is established, Sxl protein
subsequently shuts down the DCC and eliminates the very
difference in gene dose between the sexes which set in motion, as
well as augmented, its own activation. Implicit, is that before the
establishment of Sxl expression, each X-chromosome in females is
transcribed at 2X levels, as in males, and our qRT-PCR data of
some of the key sex determination genes would support this view.
The conventional X: A ratio would then be 4:2 rather than 2:2,
and in males 2:2 rather than 1:2 (Figure 9).
In that there is a 2-fold difference between the sexes, this
scenario is mathematically the same. However, there are practical
and functional implications. An X: A ratio that is transiently 4:2
rather than 2:2 in females, would have some of the X-linked genes
which activate SxlPe at twice the level of their putative
counteracting autosomal or denominator genes. In a screen which
seeks suppression of a female-specific lethal condition due to a
decrease in numerator elements, it would require the equivalent of
two autosomal genes to be mutated to reestablish an X: A ratio
favorable for female survival. Obtaining two mutations in genes
functioning in the same process at once is unlikely, which may
have skewed the outcome of screens which sought to identify
zygotic autosomal genes. It may not be a coincidence that the only
autosomal acting component identified is dpn [37,38]. As both Dpn
and Run bind the co-repressor Gro [39,40] but have opposing
effects on SxlPe, it has been speculated they may antagonize each
other [39,41]. Screens may have repeatedly identified dpn as it
would be counteracting a gene expressed at its chromosomal
equivalent, since run is not upregulated by the male DCC.
Elevated X chromosome transcription
On a more general level, our data suggest an upregulation of
transcription of the Drosophila X, and may reflect a universal
requirement of elevated X chromosome expression to avoid
monosomy. Recent microarray analysis of mouse ES cells indicates
that mammalian dosage compensation is more complex than
previously thought: there is higher expression of the X
chromosome relative to the autosomes giving them equivalence,
i.e. chromosome per chromosome the X is overexpressed by about
two-fold relative to each autosome [42–44]. As differentiation
proceeds, females lose expression of one of their X chromosomes,
silencing it through inactivation. Put in other words, the
mammalian X chromosome is not monosomic in expression but
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appears to shut down elevated X chromosome transcription in
females. (Hyperactive X chromosome expression in C. elegans has
also been suggested [42], so dosage compensation in the
hermaphrodite would then serve to lower the X chromosomes to
match autosome levels).
In this regard, Drosophila would not be very different from
mammals except that rather than inactivating one of the female
X’s, Sxl inactivates the mechanism which upregulates X
chromosome specific expression. In all cases, dosage compensation
avoids tetrasomy of the X. What the components are which
specifically upregulate the mammalian or C. elegans X chromo-
some—the Drosophila male DCC counterpart—remain to be
determined.
Materials and Methods
Fly crosses
Flies were reared under uncrowded conditions on standard
cornmeal medium. All crosses were done at 25uC; Ore R was the
wild type control. Progeny were counted out to 8 days from the
first day of eclosion. Description of genes can be found in Flybase
(http://www.flybase.org/).
In situs and immunofluorescence
These were done as in Erickson and Cline [25]. The Sxl early
(407 nt) and late (1039 nt) transcript specific probes were
generated by the primers, respectively: 59 GTTCCACTCGTGA-
CAAGTCC 39and 59 GTTTCTAAGCAGATCCCG 39;5 9
GCGAAACGTGCACACTGC 39 and 59 GGGCGATGCTTG-
CATGTTGC 39 (T7 promoter sequence removed). For hairy, the
primers 59 CCAGAACCTGCTGCTCAT TCG 39 and 59
GGGAAAGCGGCTA ACCTCGTTC 39; for sis-a the primers
59 CAAAATGCACTACGCCGACG 39 and 59 GCATCGTG-
TCCAACATGACG 39 were used. All in situs were repeated at
least once. Each batch was done simultaneously with an Ore R
control, and had sufficient embryos so that several representatives
of each cycle could be examined. M3TAP embryos [31] were
stained for Sxl (mouse) and MSL-1 (rabbit) as previously described
[45]. To enhance the MSL signal, the M3TAP was first bound
(blocked) by the same anti-rabbit fluorescent secondary used for
the anti-MSL-1 primary before addition of the primary antibody.
qRT–PCRs
Embryos were collected on apple juice agar plates for one hour
and aged for the appropriate time. They were washed off the plate,
dechorionated with 50% chlorox, washed extensively with 1x
PBST and frozen at 280uC. RNA was extracted from the frozen
embryos using tri-reagent as per manufacturer’s protocol. An
additional phenol extraction was performed on the purified RNA,
followed by DNAse treatment. A PCR test was performed on the
RNA to confirm the lack of DNA, after which 4 ug of the RNA
was reverse transcribed (RT) with AMV RT at 50uC for 15 min
followed by 1.5 h at 42uC. A small amount (2 ng) of Sxl primer (59
CGT GTC CAG CTG ATC GTC GG 39) was added to the
oligo-dT mix (100 ng) per RT, as the stage specific 59 exons of Sxl
Figure 9. Model depicting X chromosome expression levels in the two sexes. At 25uC cycle 13 is around 2 h 15 min and cycle 14 concludes
around 3 h 15 min. Reduction of the DCC effect is shown as being gradual as the female mode of Sxl splicing is established, and repression of MSL-2
expression is more complete.
doi:10.1371/journal.pgen.1001041.g009
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performed in triplicate on a Bio-Rad iQ5 thermocycler; Ct values
that showed a difference of greater than 0.5 from the other two
replicates were discarded. For each genotype a minimum of 3
separate RNA samples was analyzed. PCR products were between
200 and 300 bp; primers for SxlPe 59 CTGTTCGACCA-
TGTCGTCCTA C and CTA CCACCGCTGCCCAGCGAC,
SxlPm 59 GTGGTTATCCCCCATATGGC 39 and 59 CTA CC-
ACCGCTGCCCAGCGAC 39, sis-a 59 CGTATACGCACCG-
TATCGCGG 39 and 59 GCATCGTGTCCAACATGACG, runt
59 CGACGAAAACTACTGCGGCG 39 and CCAGCCAAGC-
GGGATTCAGC, upd 59 GAAAGCGGAACAGCAACTGG 39
and 59CAGGAACTTGTAGTTGTGCG 39, dpn 59 CCGAT-
TATGGAGAAACGTCGC 39 and 59 CTGAGCCGCTGAC-
GAACACC. Statistical data analysis was completed using
Microsoft Excel and GraphPad Prism.
Supporting Information
Figure S1 MSL-2 affects accumulation of sis-a mRNA. In situs
of embryos using a sis-a probe shows early expression (cycles 9 and
10) to be slightly lower in embryos from homozygous msl-2
1
mothers. By cycle 12, however, the levels accumulated in embryos
from msl-2
1 mothers were higher than wild type.
Found at: doi:10.1371/journal.pgen.1001041.s001 (1.00 MB TIF)
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